BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/8/2025 10:49:14 AM | Browse: 23 | Download: 5
Publication Name World Journal of Stem Cells
Manuscript ID 109862
Country Egypt
Category Cardiac & Cardiovascular Systems
Manuscript Type Basic Study
Article Title Mesenchymal stem-derived exosomes enhance therapeutic benefits of exercise in isoproterenol-induced myocardial ischemia: Targeting ERK and Akt/mTOR signaling
Manuscript Source Invited Manuscript
All Author List Asmaa M ShamsEldeen, Manar M AbdElalim, Nahed S Mohamed, Marwa M AbdelRahman, Samaa S Kamar, Dina H AbdelKader, Samar H Elsharkawy, Laila A Rashed, Salwa S Faisal, Walla’a A Osman and Asmaa M Selmy
Funding Agency and Grant Number
Corresponding Author Asmaa M ShamsEldeen, Assistant Professor, MD, Department of Physiology, Cairo University, Al-Saray Street, El Manial, Cairo 30411, Egypt. asmaa82shamseldeen@gmail.com
Key Words Myocardial infarction; Exercise; Exosomes; Sarcoplasmic endoplasmic reticulum calcium ATPase type 2; Extracellular signal-regulated kinase 1/2; Cardiac hypertrophy; Ejection fraction
Core Tip Myocardial infarction has been extensively validated in rats for reliably inducing post-infarction metabolic and histological changes. Combined therapy may target the extracellular signal-regulated kinase and protein kinase B/mammalian target of rapamycin signaling, both of which are central to the development of hypertrophic remodeling after myocardial infarction, along with the crosstalk between matrix metalloproteinase 9 and sarcoplasmic endoplasmic reticulum calcium ATPase type 2a, which maintains the balance between hypertrophic growth and contractile function. This could offer a new therapeutic regimen for treating early maladaptive left ventricular hypertrophy.
Citation ShamsEldeen AM, AbdElalim MM, Mohamed NS, AbdelRahman MM, Kamar SS, AbdelKader DH, Elsharkawy SH, Rashed LA, Faisal SS, Osman WA, Selmy AM. Mesenchymal stem-derived exosomes enhance therapeutic benefits of exercise in isoproterenol-induced myocardial ischemia: Targeting ERK and Akt/mTOR signaling. World J Stem Cells 2025; In press
Received
2025-05-26 13:39
Peer-Review Started
2025-05-26 13:39
To Make the First Decision
Return for Revision
2025-06-07 05:51
Revised
2025-06-19 22:29
Second Decision
2025-09-01 00:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-09-08 10:49
Articles in Press
2025-09-08 10:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com